BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase
inhibitors used to manage the symptoms of Alzheimer disease and other dementias; …

Introduction. Acute renal failure (ARF) develops in 33% of the patients with rhabdomyolysis.
The main etiologic factors are alcoholism, trauma, exercise overexertion, and drugs. In this …

OBJECTIVE To report a case of rhabdomyolysis and acute renal failure associated with
gemfibrozil monotherapy of hyperlipidemia. CASE SUMMARY A 30-year-old white man with …

Objective: To assess the occurrence of gastrointestinal (GI) adverse events in a national
sample of nursing home residents taking donepezil, galantamine, or rivastigmine. Design: A …

Background: Transitioning patients between cholinesterase inhibitors was thought to require
a washout period to avoid cholinergic toxicity; however, evidence suggests that abrupt …

Context Elevated total cholesterol (total‐C) and low‐density lipoprotein cholesterol (LDL‐C)
levels are established risk factors for cardiovascular disease (CVD). HMG‐CoA reductase …

Results: Numerically, more subjects on rivastigmine than on donepezil dropped out early
due to side effects (14.6% vs 11.9%). A maximum approved dose (10 mg for donepezil and …

Background Older adults are at an increased risk of delirium because of age, polypharmacy,
multiple comorbidities and acute illness. Antimuscarinics are the backbone of the …

OBJECTIVE: To report a case of rhabdomyolysis resulting from concurrent use of
cerivastatin and gemfibrozil. CASE SUMMARY: An 82-year-old white man presented to the …

Background Rhabdomyolysis with a marked elevation of serum creatine kinase (CK) can be
caused by various conditions. Acute kidney injury (AKI) is a potential complication of severe …